Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception

<div>Comparison of peak thrombin (a) and plasminogen activator inhibitor-1 (PAI-1, (b)) in 3 studied groups; ((A) the contraception-related group, (B) the unprovoked VTE group, and (C) the control group).</div>

Disease Markers

fig1

Figure 1

Figure 1: Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception 

Figure 1 | Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception 